Celanese Corporation · NYSE:CE
Celanese — Q1 2026 Earnings Presentation
14 slides from Celanese's earnings presentation, May 5, 2026
Slide 1: Investor Presentation Q1 2026
Investor Presentation Q1 2026 May 2026
Slide 2: Disclosures: Forward-Looking Statements
Celanese Corporation Disclosures Forward-Looking Statements This presentation may contain "forward-looking statements," which include information concerning Celanese Corporation’s (the “Company”) plans objectives, goals, strategies, future revenues, cash flow, financial performance, synergies, capit
Slide 3: Discussion Topics
Discussion Topics 3 Earnings update Key actions and near- term imperatives
Slide 4: Q1 2026 results and highlights
Q1 2026 results and highlights Q1 2026 Results 4 Q1 2026 Highlights * Represents a non-GAAP measure. For information on historical non-GAAP financial measures used by the Company, including definitions and reconciliations to comparable GAAP financial measures, please refer to the Non-US GAAP Financi
Slide 5: Q2 2026 outlook
Leveraged AC operating model to drive margin lift Continued focus in EM on enhanced mix and cost reductions, with moderate seasonal improvement Ongoing execution of initiatives to improve earnings resilience and offset input cost inflation Turnaround related impacts from the POM – Frankfurt
Slide 6: Continued focus on execution of actions drive sustained value creation in 2026 and beyond
Continued focus on execution of actions drive sustained value creation in 2026 and beyond 6 Generated $773 million in 2025 free cash flow* Completed refinancing of certain debt maturities Advanced deleveraging through $500 million divestiture of Micromax® Fully repaid balance on term loans,
Slide 7: Strong execution validates the differentiation and earnings power of the Acetyl Chain
Strong execution validates the differentiation and earnings power of the Acetyl Chain 7* Represents a non-GAAP measure. For information on historical non-GAAP financial measures used by the Company, including definitions and reconciliations to comparable GAAP financial measures, please refer to the
Slide 8: EM's commercial-led strategy enables growth and fortifies the operating framework
EM’s commercial-led strategy enables growth and fortifies the operating framework 8* Represents a non-GAAP measure. For information on historical non-GAAP financial measures used by the Company, including definitions and reconciliations to comparable GAAP financial measures, please refer to the Non-
Slide 9: Operational agility measures enhance the nylon platform and support the Grow and Fortify strategy
Operational agility measures enhance the nylon platform and support the Grow and Fortify strategy 9 → Improves cost position and overall competitiveness across the nylon portfolio → Simplifies and streamlines the manufacturing network to reduce inefficiencies and improve agility → Optimizes ‘make vs
Slide 10: Recent actions reflect the next milestones in our execution journey since early 2025
Recent actions reflect the next milestones in our execution journey since early 2025 10 JAN 2025 TODAY Refinanced $2.6 billion of near- term debt, materially improving maturity profile Achieved $80 million of 2025 cost reductions, exceeding original target of $75 million Announced incremental $40 mi
Slide 11: Actions underway to increase 2026 free cash flow target to $700-$800 million
Actions underway to drive earnings position us to increase 2026 free cash flow* target to $700 - $800 million 11* Represents a non-GAAP measure. For information on historical non-GAAP financial measures used by the Company, including definitions and reconciliations to comparable GAAP financial measu
Slide 12: Strong and sustainable free cash flow generation and divestitures drive deleveraging
1 2 3 1 2 3 Strong and sustainable free cash flow* generation and divestitures drive deleveraging Free Cash Flow* and Divestitures ($M) 12 Sustainable cash generation capabilities accelerate debt paydown Accelerating cash flow capabilities and strategic divestitures… * Represents a non-GAAP measure.
Slide 13: Achieved over $120M cost savings in 2025; targeting incremental opportunities in 2026
$25 $15 $30 - $50 $20 - $30 $10 - $20 $80 $10 Achieved over $120 M cost savings in 2025; targeting incremental opportunities of ~$50 M - $70 M in 2026 13 Near Term Cost Reductions Engineered Materials Complexity Reduction Acetyl Chain Productivity $90 million of targeted annualized savings primarily
Slide 14: Celanese Offers a Compelling Investment Opportunity
Celanese Offers a Compelling Investment Opportunity Our mission is to position Celanese as a top quartile company for total shareholder return by delivering earnings growth in any environment 14 Strong earnings leverage as demand recovers Actions underway to deliver near-term earnings improvement Le